1. When Using DOPPS Slides

2. DOPPS Slide Use Guidelines

3. The Survival Advantage for Hemodialysis Patients taking Vitamin D is Questioned: Findings from the Dialysis Outcomes and Practice Patterns Study

4. Introduction

5. DOPPS Background

6. Figure 1. Percentage of patients prescribed vitamin D and route of vitamin D administration in DOPPS countries at each study phase

7. Figure 2. Facility-level prescription of Vitamin D, by Region and Phase of DOPPS

8. Table 1. Patient characteristics and baseline laboratory values according to vitamin D prescription at study entry and adjusted odds ratio (AOR) for vitamin D prescription

9. Table 1 (cont.)

10. Table 2. Factors significantly associated with vitamin D initiation and cessation

11. Table 2 (cont.)

14. Table 3. Patient characteristics at facilities with vitamin D prescription below or above the regional median a

15. Table 3 (cont.)

16. Table 4. Mortality risk and vitamin D prescription

17. Summary

18. Summary (cont.)

19. Acknowledgements